These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7764531)

  • 1. Monoclonal antibody process development using medium concentrates.
    Bibila TA; Ranucci CS; Glazomitsky K; Buckland BC; Aunins JG
    Biotechnol Prog; 1994; 10(1):87-96. PubMed ID: 7764531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting monoclonal antibody production in culture.
    Reuveny S; Velez D; Macmillan JD; Miller L
    Dev Biol Stand; 1987; 66():169-75. PubMed ID: 3582746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-yielding, generic fed-batch cell culture process for production of recombinant antibodies.
    Sauer PW; Burky JE; Wesson MC; Sternard HD; Qu L
    Biotechnol Bioeng; 2000 Mar; 67(5):585-97. PubMed ID: 10649233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In pursuit of the optimal fed-batch process for monoclonal antibody production.
    Bibila TA; Robinson DK
    Biotechnol Prog; 1995; 11(1):1-13. PubMed ID: 7765983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-free fed-batch culture of non-GS NS0 cell lines for production of recombinant antibodies.
    Burky JE; Wesson MC; Young A; Farnsworth S; Dionne B; Zhu Y; Hartman TE; Qu L; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):281-93. PubMed ID: 16933323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heuristic optimization of antibody production by Chinese hamster ovary cells.
    Sandadi S; Ensari S; Kearns B
    Biotechnol Prog; 2005; 21(5):1537-42. PubMed ID: 16209559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feed development for fed-batch CHO production process by semisteady state analysis.
    Khattak SF; Xing Z; Kenty B; Koyrakh I; Li ZJ
    Biotechnol Prog; 2010; 26(3):797-804. PubMed ID: 20014108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous production of monoclonal antibody in a packed-bed bioreactor.
    Golmakany N; Rasaee MJ; Furouzandeh M; Shojaosadati SA; Kashanian S; Omidfar K
    Biotechnol Appl Biochem; 2005 Jun; 41(Pt 3):273-8. PubMed ID: 15506916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated dynamic fed-batch process and media optimization for high productivity cell culture process development.
    Lu F; Toh PC; Burnett I; Li F; Hudson T; Amanullah A; Li J
    Biotechnol Bioeng; 2013 Jan; 110(1):191-205. PubMed ID: 22767053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.
    Seifert DB; Phillips JA
    Biotechnol Prog; 1999; 15(4):655-66. PubMed ID: 10441357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot-scale production of murine monoclonal antibodies in agitated, ceramic-matrix or hollow-fiber cell culture systems.
    Kurkela R; Fraune E; Vihko P
    Biotechniques; 1993 Oct; 15(4):674-83. PubMed ID: 8251170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-line purification of monoclonal antibodies using an integrated stirred-tank reactor/expanded-bed adsorption system.
    Ohashi R; Otero JM; Chwistek A; Yamato I; Hamel JF
    Biotechnol Prog; 2002; 18(6):1292-300. PubMed ID: 12467465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical methods in media optimization for batch and fed-batch animal cell culture.
    De Alwis DM; Dutton RL; Scharer J; Moo-Young M
    Bioprocess Biosyst Eng; 2007 Mar; 30(2):107-13. PubMed ID: 17242929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidation of metabolism in hybridoma cells grown in fed-batch culture by genome-scale modeling.
    Selvarasu S; Wong VV; Karimi IA; Lee DY
    Biotechnol Bioeng; 2009 Apr; 102(5):1494-504. PubMed ID: 19048615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-end pH-controlled delivery of glucose effectively suppresses lactate accumulation in CHO fed-batch cultures.
    Gagnon M; Hiller G; Luan YT; Kittredge A; DeFelice J; Drapeau D
    Biotechnol Bioeng; 2011 Jun; 108(6):1328-37. PubMed ID: 21328318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High-cell density cultivation of recombinant Escherichia coli for production of TRAIL by using a 2-stage feeding strategy].
    Zhang Y; Shen YL; Xia XX; Sun AY; Wei DZ; Zhou JS; Zhang GJ; Wang LH; Jiao BH
    Sheng Wu Gong Cheng Xue Bao; 2004 May; 20(3):408-13. PubMed ID: 15971615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved fermentation processes for NS0 cell lines expressing human antibodies and glutamine synthetase.
    Dempsey J; Ruddock S; Osborne M; Ridley A; Sturt S; Field R
    Biotechnol Prog; 2003; 19(1):175-8. PubMed ID: 12573022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of nutritional factors and physical conditions affecting growth and monoclonal antibody production of the hybridoma KB-26.5 cell line.
    Sanfeliu A; Cairo JJ; Casas C; Sola C; Godia F
    Biotechnol Prog; 1996; 12(2):209-16. PubMed ID: 8857191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the intracellular effect of enhanced nutrient feeding toward high titer antibody production process.
    Yu M; Hu Z; Pacis E; Vijayasankaran N; Shen A; Li F
    Biotechnol Bioeng; 2011 May; 108(5):1078-88. PubMed ID: 21165902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of medium composition on hybridoma growth and antibody production.
    Hencsey Z; Fizil A; Inzelt-Kovács M; Veszely G; Bánkúti L
    Acta Microbiol Immunol Hung; 1996; 43(4):359-70. PubMed ID: 9147727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.